318 related articles for article (PubMed ID: 32636240)
1. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy.
Koti M; Morales A; Graham CH; Siemens DR
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32636240
[TBL] [Abstract][Full Text] [Related]
2. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
3. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
4. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again?
O'Connor E; Teh J; Kamat AM; Lawrentschuk N
Future Oncol; 2020 Jul; 16(19):1323-1325. PubMed ID: 32406253
[No Abstract] [Full Text] [Related]
6. BCG as a game-changer to prevent the infection and severity of COVID-19 pandemic?
Sharma AR; Batra G; Kumar M; Mishra A; Singla R; Singh A; Singh RS; Medhi B
Allergol Immunopathol (Madr); 2020; 48(5):507-517. PubMed ID: 32653224
[TBL] [Abstract][Full Text] [Related]
7. [Progress in possible effects of BCG vaccine on the prevention of SARS-CoV-2 infection: An update].
Huang W; Liu T; Feng G; Wang X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):1044-1048. PubMed ID: 33210600
[TBL] [Abstract][Full Text] [Related]
8. BCG-induced trained immunity: can it offer protection against COVID-19?
O'Neill LAJ; Netea MG
Nat Rev Immunol; 2020 Jun; 20(6):335-337. PubMed ID: 32393823
[TBL] [Abstract][Full Text] [Related]
9. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
Gupta PK
Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
[TBL] [Abstract][Full Text] [Related]
10. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
Front Immunol; 2020; 11():970. PubMed ID: 32574258
[TBL] [Abstract][Full Text] [Related]
11. Impact of Routine Infant BCG Vaccination on COVID-19.
Kinoshita M; Tanaka M
J Infect; 2020 Oct; 81(4):625-633. PubMed ID: 32795481
[TBL] [Abstract][Full Text] [Related]
12. BCG versus COVID-19?
Kantor IN
Medicina (B Aires); 2020; 80(3):292-294. PubMed ID: 32442946
[No Abstract] [Full Text] [Related]
13. COVID-19 vaccination clinical trials should consider multiple doses of BCG.
Ayoub BM
Pharmazie; 2020 Apr; 75(4):159. PubMed ID: 32295694
[No Abstract] [Full Text] [Related]
14. Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.
Glisic S; Perovic VR; Sencanski M; Paessler S; Veljkovic V
J Proteome Res; 2020 Nov; 19(11):4649-4654. PubMed ID: 32794723
[TBL] [Abstract][Full Text] [Related]
15. Stop playing with data: there is no sound evidence that Bacille Calmette-Guérin may avoid SARS-CoV-2 infection (for now).
Riccò M; Gualerzi G; Ranzieri S; Bragazzi NL
Acta Biomed; 2020 May; 91(2):207-213. PubMed ID: 32420947
[TBL] [Abstract][Full Text] [Related]
16. BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
Tomita Y; Sato R; Ikeda T; Sakagami T
Vaccine; 2020 Sep; 38(41):6352-6356. PubMed ID: 32863070
[TBL] [Abstract][Full Text] [Related]
17. Concern over a COVID-19-related BCG shortage.
Namkoong H; Horita N; Ebina-Shibuya R
Int J Tuberc Lung Dis; 2020 Jun; 24(6):642-643. PubMed ID: 32552997
[No Abstract] [Full Text] [Related]
18. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.
Gatto L; Franceschi E; Nunno VD; Brandes AA
Immunotherapy; 2020 Oct; 12(15):1111-1114. PubMed ID: 32594820
[No Abstract] [Full Text] [Related]
19. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
20. Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
Schaaf HS; du Preez K; Kruger M; Solomons R; Taljaard JJ; Rabie H; Seddon JA; Cotton MF; Tebruegge M; Curtis N; Hesseling AC
Int J Tuberc Lung Dis; 2020 Jul; 24(7):732-734. PubMed ID: 32718410
[No Abstract] [Full Text] [Related]
[Next] [New Search]